Campbell & Co. Investment Adviser »

Kymera Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-09-30 $259k 4.6k 56.60
2024-12-31 $745k 19k 40.23
2024-09-30 $1.4M 30k 47.33
2024-03-31 $1.4M 35k 40.20

More positions owned by Campbell & Co. Investment Adviser

Wheaton Precious Metals Corp Common Stock (WPM)
Rio Tinto Adr (RIO)
Sprouts Farmers Market Common Stock (SFM)
PTC Common Stock (PTC)
Agnico Eagle Mines Common Stock (AEM)
OGE Energy Corp Common Stock (OGE)
Paychex Common Stock (PAYX)
CMS Energy Corp Common Stock (CMS)
Royal Gold Common Stock (RGLD)
Logitech International SA Common Stock (LOGI)
Franklin Resources Common Stock (BEN)
Meta Platforms Common Stock (META)
Graphic Packaging Holding Common Stock (GPK)
Kinder Morgan Common Stock (KMI)
Pan American Silver Corp Common Stock (PAAS)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Kymera Therapeutics

Baker Bros. Advisors
venBio Select Advisor
FMR
BVF
Vanguard Group
Wellington Management Company
Atlas Venture Life Science Advisors
BlackRock
Siren
State Street Corporation
Geode Capital Management
Capital Research Global Investors
Jennison Associates
Driehaus Capital Management
Ubs Global Asset Management Americas

View all funds holding Kymera Therapeutics